Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by Pzena Investment Management LLC

Pzena Investment Management LLC lessened its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 10.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,302,780 shares of the company’s stock after selling 158,020 shares during the quarter. Pzena Investment Management LLC owned about 3.22% of Phibro Animal Health worth $27,358,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Quantbot Technologies LP acquired a new position in shares of Phibro Animal Health during the third quarter valued at approximately $70,000. New York State Teachers Retirement System increased its stake in shares of Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after acquiring an additional 775 shares during the period. Amundi increased its stake in shares of Phibro Animal Health by 185.5% during the fourth quarter. Amundi now owns 9,855 shares of the company’s stock valued at $212,000 after acquiring an additional 6,403 shares during the period. Zacks Investment Management acquired a new position in shares of Phibro Animal Health during the third quarter valued at approximately $274,000. Finally, SG Americas Securities LLC increased its stake in shares of Phibro Animal Health by 7.4% during the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock valued at $276,000 after acquiring an additional 906 shares during the period. Institutional investors and hedge funds own 99.34% of the company’s stock.

Wall Street Analyst Weigh In

PAHC has been the topic of a number of research analyst reports. StockNews.com lowered shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Friday. Morgan Stanley raised their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Finally, Barclays raised their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Two analysts have rated the stock with a sell rating and three have issued a hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Trading Down 1.7 %

Shares of NASDAQ:PAHC opened at $23.23 on Tuesday. The stock has a market capitalization of $940.88 million, a price-to-earnings ratio of 48.40, a PEG ratio of 0.45 and a beta of 0.58. Phibro Animal Health Co. has a 1-year low of $11.98 and a 1-year high of $26.55. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The company has a 50 day moving average price of $22.51 and a 200 day moving average price of $22.57.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, research analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.07%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s payout ratio is 100.00%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.